Adial Pharmaceuticals Earning Date (ADIL)

USA |NASDAQ |USD

ADIL Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
May 17, 2022 (est) Mar 31, 2022 $-0.17 $-0.28 $-0.30
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
May 17, 2022 (est) Mar 31, 2022 $0.00 $0.00 $0.00

Adial Pharmaceuticals's next estimated earnings date (based on same quarter last year's date) is May 17, 2022 for the fiscal quarter ending Mar 31, 2022.

ADIL Earnings Date & History Chart

ADIL Earnings & Revenue Forecast

ADIL Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 1 $-0.17 $-0.17 $-0.17
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $-0.64 $-0.67 $-0.62
Dec 2023 2 $-0.14 $-0.22 $-0.06

ADIL Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 0 / 0 $-0.17 $-0.17 $-0.17
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 1 / 0 $-0.71 $-0.71 $-0.75
Dec 2023 0 / 0 $-0.14 $-0.14 $-0.14

ADIL Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 1 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $0.00 $0.00 $0.00
Dec 2023 2 $11.79M $0.00 $23.58M

ADIL Earnings Date & Revenue History

ADIL Earnings History

|
Show More
Show More

ADIL Revenue History

|
Show More
Show More

Adial Pharmaceuticals Next Earnings Date & Report

ADIL Mar 2022 (FQ) Earnings Date & Report Preview

ADIL's next estimated earnings date (based on same quarter last year's report date) is May 17, 2022 for the fiscal quarter ending Mar 31, 2022.

Adial Pharmaceuticals Previous Earnings Dates & Reports

ADIL Previous Earnings Date & Report Recap: Dec 2021 (FQ)

Adial Pharmaceuticals's previous earnings date was Mar 28, 2022 for its fiscal quarter ended Dec 31, 2021.

ADIL's earnings per share (EPS) was $-0.28, missing the consensus analysts forecast of $-0.21 by -33.33%.

The EPS was lower than the previous fiscal quarter (Sep 2021) by 27.27%, and lower than the same period a year before (Dec 2020) by 12.00%.

Revenues were $0.00.

The company reported a net income of $-5.83M.

Free cash flow for the quarter was $-2.37M , compared to $-3.53M last quarter and $-2.61M a year before.

ADIL Previous Earnings Date & Report Recap: Dec 2021 (FY)

Adial Pharmaceuticals's previous annual earnings date was Mar 28, 2022 for its fiscal year ended Dec 31, 2021.

ADIL's earnings per share (EPS) was $-1.05, missing the consensus analysts forecast of $-0.96 by 9.38% , and lower than the previous year's EPS (Dec 2020) by 20.69%.

Revenues were $0.00.

The company reported a net income of $-19.42M.

Adial Pharmaceuticals reported a free cash flow of $-12.01M for its fiscal year, compared to $-7.63M a year ago.